Preferred
(EDT)
Hematologic Malignancies: Biology and Therapy
10:00 AM - 1:00 PM EDT
Friday, April 23, 2021Room: Multi-Room Split Session Co-Chairs
Speakers
Kate Yen, PhD
Auron Therapeutics
Melvin Thomas III, PhD
St. Jude Children's Research Hospital
Panagiotis Ntziachristos, PhD
Northwestern University
Elvin Wagenblast, PhD
University Health Network, Princess Margaret Cancer Centre
Liping Li, MD, PhD
Johns Hopkins University
Shailaja Hegde, PhD
University of Cincinnati
Michael Lawler, MS
Thomas Jefferson University
Other
Hematologic Malignancies: Biology and Therapy
Reprogramming B-ALL into APCs for Cancer Vaccination
10:00 AM - 10:25 AM EDT
Friday, April 23, 2021Room: V100 - Ben Schramm Speaker
Ravi Majeti, MD, PhD
Stanford University
Hematologic Malignancies: Biology and Therapy
Differentiation Therapy in AML
10:25 AM - 10:50 AM EDT
Friday, April 23, 2021Room: V100 - Ben Schramm Speaker
Kate Yen, PhD
Auron Therapeutics
Hematologic Malignancies: Biology and Therapy
Innate Immune Deaminases Fuel Pre-Leukemia Stem Cell Malignant Transformation
10:50 AM - 11:15 AM EDT
Friday, April 23, 2021Room: V100 - Ben Schramm Speaker
Catriona Jamieson, MD, PhD
University of California, San Diego
Hematologic Malignancies: Biology and Therapy
Coffee Break
11:15 AM - 11:30 AM EDT
Friday, April 23, 2021Hematologic Malignancies: Biology and Therapy
Short Talk: Germline Mutations in SAMD9 and SAMD9L Impair Hematopoietic Cell Function
11:30 AM - 11:45 AM EDT
Friday, April 23, 2021Room: V300 - Chad Littman Speaker
Melvin Thomas III, PhD
St. Jude Children's Research Hospital
Hematologic Malignancies: Biology and Therapy
Short Talk: Characterizing Mechanisms Controlling Aberrant Spliceosome Levels and Its Impact on Therapy Response in Acute Lymphoblastic Leukemia
11:45 AM - 12:00 PM EDT
Friday, April 23, 2021Room: V300 - Chad Littman Speaker
Panagiotis Ntziachristos, PhD
Northwestern University
Hematologic Malignancies: Biology and Therapy
Short Talk: Mapping the Cellular Origin and Developmental Context of Myeloid Leukemia in Down Syndrome
12:00 PM - 12:15 PM EDT
Friday, April 23, 2021Room: V300 - Chad Littman Speaker
Elvin Wagenblast, PhD
University Health Network, Princess Margaret Cancer Centre
Hematologic Malignancies: Biology and Therapy
Short Talk: High Mobility Group A1 Chromatin Remodeling Proteins Drive Progression in Myeloproliferative Neoplasms through Epigenetic Rewiring to Induce GATA2 and Cell Cycle Progression
12:15 PM - 12:30 PM EDT
Friday, April 23, 2021Room: V300 - Chad Littman Speaker
Liping Li, MD, PhD
Johns Hopkins University
Hematologic Malignancies: Biology and Therapy
Short Talk: Cell Basal Polarity Complex Scribble Is Required for Leukemic Initiation and Propagation through Negative Regulation of Apical Polarity Complex Activator Cdc42 and Hypoxia Inducing Factor-1α
12:30 PM - 12:45 PM EDT
Friday, April 23, 2021Room: V300 - Chad Littman Speaker
Shailaja Hegde, PhD
University of Cincinnati
Hematologic Malignancies: Biology and Therapy
Short Talk: Interrogation of TLR2 Inflammatory Signaling in AML
12:45 PM - 1:00 PM EDT
Friday, April 23, 2021Room: V300 - Chad Littman Speaker
Michael Lawler, MS
Thomas Jefferson University
Hematologic Malignancies: Biology and Therapy
